Viability of umbilical cord blood mononuclear cell subsets until 96 hours after collection

Transfusion

Volumn 53, Issue 9, 2013, Pages 2034-2042

  Pereira Cunha, Fernanda G ^a   Duarte, Adriana S S ^a   Costa, Fernando F ^a   Saad, Sara T O ^a   Lorand Metze, Irene ^a   Luzo, Angela C M ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CD34 SELECTION; CELL VIABILITY; CESAREAN SECTION; CLONOGENIC ASSAY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MONOCYTE; MONONUCLEAR CELL; PRE B LYMPHOCYTE; ROOM TEMPERATURE; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; B-LYMPHOCYTES; BLOOD BANKS; BRAZIL; CELL SURVIVAL; CRYOPRESERVATION; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES;

EID: 84883850226     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12078     Document Type: Article

References (38)

1. Rubinstein P,. Cord blood banking for clinical transplantation. Bone Marrow Transplant 2009; 44: 635-642.
2. Broxmeyer HE, Cooper S, Hass DM, Hathaway JK, Stehman FB, Hangoc G,. Experimental basis of cord blood transplantation. Bone Marrow Transplant 2009; 44: 627-633.
3. Arcese W, Buccisano F, Cerretti R,; Picardi A for the Rome Transplant Network. Cord blood transplantation in adults with acute myeloid leukaemia. Best Pract Res Clin Haematol 2010; 23: 197-206.
4. Brunstein CG, Fuchs EJ, Carter SL, Karanes C, Costa LJ, Wu J, Devine SM, Wingard JR, Aljitawi OS, Cutler CS, Jagasia MH, Ballen KK, Eapen M, O'Donnell PV,; Blood and Marrow Transplant Clinical Trials Network. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood 2011; 118: 282-288.
5. Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Lo Nigro L, Ayas M, Purtill D, Boudjedir K, Chaves W, Walters MC, Wagner J, Gluckman E, Rocha V,; Eurocord Registry; Center for International Blood and Marrow Transplant Research; New York Blood Center. Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant 2011; 17: 1375-1382.
6. Fukunaga A, Nakamura F, Yoshinaga N, Inano S, Maruyama W, Hirata H, Arima N,. Successful treatment with combined chemotherapy of two adult cases of hemophagocytic lymphohistiocytosis in recipients of umbilical cord blood cell transplantation. Int J Hematol 2011; 93: 551-554.
7. Kogler G, Critser P, Trapp T, Yoder M,. Future of cord blood for non-oncology uses. Bone Marrow Transplant 2009; 44: 683-697.
8. Kaner T, Karadag T, Cirak B, Erken HA, Karabulut A, Kiroglu Y, Akkaya S, Acar F, Coskun E, Genc O, Colakoglu N,. The effects of human umbilical cord blood transplantation in rats with experimentally induced spinal cord injury. J Neurosurg Spine 2010; 13: 543-551.
9. Boltze J, Schmidt UR, Reich DM, Kranz A, Reymann KG, Strassburger M, Lobsien D, Wagner DC, Förschler A, Schäbitz WR,. Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats. Cell Transplant 2012; 21: 1199-1211.
10. Lim JY, Jeong CH, Jun JA, Kim SM, Ryu CH, Hou Y, Oh W, Chang JW, Jeun SS,. Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther 2011; 2: 38.
11. Kim YJ, Broxmeyer HE,. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance. Crit Rev Oncol Hematol 2011; 79: 12-126.
12. Wagner E, Duval M, Dalle JH, Morin H, Bizier S, Champagne J, Champagne MA,. Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks. Transfusion 2006; 46: 1190-1198.
13. Querol S, Gomez SG, Pagliuca A, Torrabadella M, Madrigal JA,. Quality rather than quantity: the cord blood bank dilema. Bone Marrow Transplant 2010; 45: 970-978.
14. Picardi A, Arcese W,. Quality assessment of cord blood units selected for unrelated transplantation: a transplant center perspective. Transfus Apher Sci 2010; 42: 289-297.
15. Kudo Y, Minegishi M, Seki O, Takahashi H, Suzuki A, Narita A, Sato Y, Abe M, Ishioka N, Harigae H, Tsuchiya S,. Quality assessment of umbilical cord blood units at the time of transplantation. Int J Hematol 2011; 93: 645-651.
16. Flores AI, McKenna DH, Montalbán MA, De la Cruz J, Wagner JE, Bornstein R,. Consistency of the initial cell acquisition procedure is critical to the standardization of CD34+ cell enumeration by flow cytometry: results of a pair wise analysis of umbilical cord blood units and cryopreserved aliquots. Transfusion 2009; 49: 636-647.
17. Brand A, Eichler H, Szczepiorkowski ZM, Hess JR, Kekomaki R, McKenna DH, Pamphilon D, Reems J, Sacher RA, Takahashi TA, van de, Watering LM,; Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Viability does not necessarily reflect the hematopoietic progenitors cell potency of a cord blood unit: results of an interlaboratory exercise. Transfusion 2008; 48: 546-549.
18. Lopes MC, Lawrence DA,. Proficiency testing experience for viable CD34+ stem cell analysis. Transfusion 2008; 48: 1115-1121.
19. Pamphilon DH, Selogie E, Szczepiorkowski ZM,. Transportation of cellular therapy products: report of a survey by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) collaborative. Vox Sang 2010; 99: 168-173.
20. Solomon M, Wofford J, Johnson C, Regan D, Creer MH,. Factors influencing cord blood viability assessment before cryopreservation. Transfusion 2010; 50: 820-830.
21. Pamphilon D, Curnow E, Belfield H, Reems JA, McMannis J, Lecchi L, Szczepiorkowski Z, McKenna D,. Storage characteristics of cord blood progenitor cells: report of a multicenter study by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion 2011; 51: 1284-1290.
22. Duggleby RC, Querol S, Davy RC, Fry LJ, Gibson DA, Horton RB, Mahmood SN, Gomez SG, Madrigal JA,. Flow cytometry assessment of apoptotic CD34+ cells by annexin V labeling may improve prediction of cord blood potency for engraftment. Transfusion 2012; 52: 549-559.
23. Schmutz N, Henry E, Jopling J, Christensen RD,. Expected ranges for blood neutrophil concentrations of neonates: the Manroe and Mouzinho charts revisited. J Perinatol 2008; 28: 275-281.
24. Proytcheva MA,. Issues in neonatal cellular analysis. Am J Clin Pathol 2009; 131: 560-573.
25. Shearer WT, Rosenblatt HM, Gelman RS, Oyomopito R, Plaeger S, Stiehm ER, Wara DW, Douglas SD, Luzuriaga K, McFarland EJ, Yogev R, Rathore MH, Levy W, Graham BL, Spector SA,; Pediatric AIDS Clinical Trials Group. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003; 112: 973-980.
26. Lopez MC, Palmer BE, Lawrence DA,. Phenotypic differences between cord blood and adult peripheral blood. Cytometry B Clin Cytom 2009; 76B: 37-46.
27. Borges-Almeida E, Milanez HM, Vilela MM, Cunha FG, Abramczuk BM, Reis-Alves SC, Metze K, Lorand-Metze I,. The impact of maternal HIV infection on cord blood lymphocyte subsets and cytokine profile in exposed non-infected newborns. BMC Infect Dis 2011; 11: 38.
28. Durandy A, Thuillier L, Forveille M, Fischer A,. Phenotypic and functional characteristics of human newborns' B lymphocytes. J Immunol 1990; 144: 60-65.
29. Trébéden-Negre H, Rosenzwajg M, Tanguy ML, Lefrer F, Azar N,. Delay recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft. Transfusion 2010; 50: 2649-2659.
30. Chamberlain G, Fox J, Ashton B, Middleton J,. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749.
31. Locatelli F, Maccario R, Frassoni F,. Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders? Haematologica 2007; 92: 873-877.
32. Doorn J, Moll G, Le Blanc K, van, Blitterswijk C, de, Boer J,. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements. Tissue Eng Part B Rev 2012; 18: 11-115.
33. Svensson B, Nagubothu SR, Cedervall J, Chan RW, Le Blanc K, Kimura M, Ährlund-Richter L, Tolf A, Hertegård S,. Injection of human mesenchymal stem cells improves healing of vocal folds after scar excision-a xenograft analysis. Laryngoscope 2011; 121: 2185-2190.
34. Helgason CD, Miller CL,. Methods in molecular biology, vol. 290. Totowa (NJ): Humana Press; 2005.
35. Page KM, Zhang L, Mendizabal A, Wease S, Carter S, Gentry T, Balber AE, Kurtzberg J,. Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants. Biol Blood Marrow Transplant 2011; 17: 1362-1374.
36. Le Blanc K, Tammika C, Rosendahl K, Zetterberg E, Ringdén O,. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-896.
37. Page KM, Zhang L, Mendizabal A, Wease S, Carter S, Shoulars K, Gentry T, Balber AE, Kurtzberg J,. The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME). Transfusion 2012; 52: 272-283.
38. Thornton CA, Capristo CC, Power LL, Holloway JA, Popplewell EJ, Diaper ND, Warner JO,. The effect of labor on neonatal T-cell phenotype and function. Pediatr Res 2003; 54: 120-124.